Example: Heart Attack

Search clinical trials for: Estramustine

Total 54 results

NCT02866955

Completed

Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.

Conditions: Breast Cancer
NCT02853071

Withdrawn

Efficacy and Safety of Estracyt® in Metastatic Breast Cancer

Conditions: Breast Cancer
NCT02788201

Completed

Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma

Conditions: Urothelial Carcinoma; Bladder Cancer; Urinary Bladder Neoplasms
NCT02560051

Terminated

Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer

Conditions: Prostatic Neoplasms
NCT02494713

Terminated

Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT01250717

Completed

Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer

Conditions: Prostate Cancer
NCT01084759

Completed

A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer

Conditions: Prostate Cancer
NCT00705822

Terminated

Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer

Conditions: Prostatic Neoplasms
NCT00699751

Completed

A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases

Conditions: Hormone Refractory Prostate Cancer; Bone Metastases
NCT00541281

Completed

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

Conditions: Hormone Resistant Prostate Cancer; Metastatic Prostate Cancer
NCT00218205

Unknown status

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Conditions: Prostate Cancer
NCT00193193

Completed

Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma

Conditions: Prostate Cancer
NCT00193271

Completed

Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

Conditions: Prostate Cancer
NCT00183924

Completed

Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.

Conditions: Prostate Adenocarcinoma
NCT00176527

Terminated

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Conditions: Prostate Cancer
NCT00165399

Completed

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Conditions: Adenocarcinoma of the Prostate; Prostate Cancer
NCT00151060

Completed

Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate

Conditions: Prostate Cancer
NCT00151073

Completed

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate

Conditions: Hormone-Refractory Prostate Cancer
NCT00151086

Completed

Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

Conditions: Prostate Cancer
NCT00132756

Terminated

Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

Conditions: Prostate Cancer
NCT00126230

Terminated

Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer

Conditions: Prostate Cancer
NCT00002775

Unknown status

Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Conditions: Prostate Cancer
NCT00005048

Completed

Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Conditions: Prostate Cancer
NCT00084565

Withdrawn

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

Conditions: Prostate Cancer
NCT00003584

Completed

Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer

Conditions: Kidney Cancer
NCT00002721

Completed

Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Conditions: Prostate Cancer
NCT00004105

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

Conditions: Leukemia; Lymphoma; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
NCT00003084

Completed

Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00003614

Completed

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Conditions: Prostate Cancer
NCT00083005

Completed

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Conditions: Prostate Cancer
NCT00003394

Completed

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Conditions: Prostate Cancer
NCT00005810

Completed

Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy

Conditions: Prostate Cancer
NCT00003717

Unknown status

Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

Conditions: Prostate Cancer
NCT00021372

Completed

Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00003066

Unknown status

Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer

Conditions: Breast Cancer
NCT00014352

Completed

Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer; Thromboembolism
NCT00016107

Completed

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer

Conditions: Adenocarcinoma of the Prostate; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate Cancer
NCT00055731

Active, not recruiting

Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse

Conditions: Prostate Cancer
NCT00002855

Completed

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Conditions: Prostate Cancer
NCT00003633

Unknown status

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Conditions: Prostate Cancer
NCT00004001

Completed

S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy

Conditions: Prostate Cancer
NCT00004054

Completed

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00005627

Completed

Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Conditions: Prostate Cancer
NCT00005847

Completed

Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Conditions: Prostate Cancer
NCT00016913

Completed

Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Conditions: Prostate Cancer
NCT00024167

Terminated

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00025194

Completed

Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer

Conditions: Prostate Cancer
NCT00027859

Completed

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer
NCT00028769

Completed

S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

Conditions: Prostate Cancer
NCT00030654

Completed

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Conditions: Prostate Cancer

Search clinical trials for: Estramustine

Recent CRA jobs

Safety Admin

Research Scientist - LCMS - Method Development

Data Analyst II – Real World Evidence

Clinical Team Manager (Local Study Manager) FSP

Senior Logistics Coordinator / Senior Sample Coordinator - Sample Management , LIMS , GMP

Associate HR Director - Business Partner

Associate Scientist - Part-time Weekends

QC Reviewer / Senior QC Reviewer - LIMS , GMP

Site Alliance Manager

Principal Clinical Database Programmer